Hirosaki University, Ezose unite to identify prostate cancer biomarkers

04/24/2012 | GenomeWeb Daily News (free registration)

Japan's Hirosaki University and Ezose Sciences agreed to work together to find biomarkers that can be used to predict and monitor the progress of prostate cancer and other urological cancers. Ezose will receive development and commercialization rights to the biomarkers.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI